Global Late Stage Chronic Kidney Disease Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Late Stage Chronic Kidney Disease Drugs Market Overview

• 1.1 Product Overview and Scope of Late Stage Chronic Kidney Disease Drugs
• 1.2 Classification of Late Stage Chronic Kidney Disease Drugs by Types
  • 1.2.1 Global Late Stage Chronic Kidney Disease Drugs Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share by Types in 2018
  • 1.2.3 Calcimimetics
  • 1.2.4 Vitamin D Sterols
  • 1.2.5 Potassium Binders
  • 1.2.6 Others
• 1.3 Global Late Stage Chronic Kidney Disease Drugs Market by Application
  • 1.3.1 Global Late Stage Chronic Kidney Disease Drugs Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Online Pharnacies
  • 1.3.4 Retail Pharmacies
• 1.4 Global Late Stage Chronic Kidney Disease Drugs Market by Regions
  • 1.4.1 Global Late Stage Chronic Kidney Disease Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Late Stage Chronic Kidney Disease Drugs Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Late Stage Chronic Kidney Disease Drugs Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Late Stage Chronic Kidney Disease Drugs Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Late Stage Chronic Kidney Disease Drugs Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Late Stage Chronic Kidney Disease Drugs Status and Prospect (2014-2024)
• 1.5 Global Market Size of Late Stage Chronic Kidney Disease Drugs (2014-2024)

2 Company Profiles

• 2.1 AbbVie
  • 2.1.1 Business Overview
  • 2.1.2 Late Stage Chronic Kidney Disease Drugs Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 AbbVie Late Stage Chronic Kidney Disease Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 OPKO Health
  • 2.2.1 Business Overview
  • 2.2.2 Late Stage Chronic Kidney Disease Drugs Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 OPKO Health Late Stage Chronic Kidney Disease Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 AstraZeneca
  • 2.3.1 Business Overview
  • 2.3.2 Late Stage Chronic Kidney Disease Drugs Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 AstraZeneca Late Stage Chronic Kidney Disease Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Amgen
  • 2.4.1 Business Overview
  • 2.4.2 Late Stage Chronic Kidney Disease Drugs Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Amgen Late Stage Chronic Kidney Disease Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Kyowa Hakko Kirin
  • 2.5.1 Business Overview
  • 2.5.2 Late Stage Chronic Kidney Disease Drugs Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Kyowa Hakko Kirin Late Stage Chronic Kidney Disease Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Ardelyx
  • 2.6.1 Business Overview
  • 2.6.2 Late Stage Chronic Kidney Disease Drugs Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Ardelyx Late Stage Chronic Kidney Disease Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Sanofi
  • 2.7.1 Business Overview
  • 2.7.2 Late Stage Chronic Kidney Disease Drugs Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Sanofi Late Stage Chronic Kidney Disease Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Akebia Therapeutics
  • 2.8.1 Business Overview
  • 2.8.2 Late Stage Chronic Kidney Disease Drugs Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Akebia Therapeutics Late Stage Chronic Kidney Disease Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Deltanoid
  • 2.9.1 Business Overview
  • 2.9.2 Late Stage Chronic Kidney Disease Drugs Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Deltanoid Late Stage Chronic Kidney Disease Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Vifor Pharma
  • 2.10.1 Business Overview
  • 2.10.2 Late Stage Chronic Kidney Disease Drugs Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Vifor Pharma Late Stage Chronic Kidney Disease Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Shield Therapeutics
  • 2.11.1 Business Overview
  • 2.11.2 Late Stage Chronic Kidney Disease Drugs Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Shield Therapeutics Late Stage Chronic Kidney Disease Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 ZS Pharma
  • 2.12.1 Business Overview
  • 2.12.2 Late Stage Chronic Kidney Disease Drugs Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 ZS Pharma Late Stage Chronic Kidney Disease Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Shire
  • 2.13.1 Business Overview
  • 2.13.2 Late Stage Chronic Kidney Disease Drugs Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Shire Late Stage Chronic Kidney Disease Drugs Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Spectrum
  • 2.14.1 Business Overview
  • 2.14.2 Late Stage Chronic Kidney Disease Drugs Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Spectrum Late Stage Chronic Kidney Disease Drugs Revenue, Gross Margin and Market Share (2017-2018)

3 Global Late Stage Chronic Kidney Disease Drugs Market Competition, by Players

• 3.1 Global Late Stage Chronic Kidney Disease Drugs Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Late Stage Chronic Kidney Disease Drugs Players Market Share
  • 3.2.2 Top 10 Late Stage Chronic Kidney Disease Drugs Players Market Share
• 3.3 Market Competition Trend

4 Global Late Stage Chronic Kidney Disease Drugs Market Size by Regions

• 4.1 Global Late Stage Chronic Kidney Disease Drugs Revenue and Market Share by Regions
• 4.2 North America Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 4.3 Europe Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 4.5 South America Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)

5 North America Late Stage Chronic Kidney Disease Drugs Revenue by Countries

• 5.1 North America Late Stage Chronic Kidney Disease Drugs Revenue by Countries (2014-2019)
• 5.2 USA Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 5.3 Canada Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)

6 Europe Late Stage Chronic Kidney Disease Drugs Revenue by Countries

• 6.1 Europe Late Stage Chronic Kidney Disease Drugs Revenue by Countries (2014-2019)
• 6.2 Germany Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 6.3 UK Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 6.4 France Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 6.5 Russia Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 6.6 Italy Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Revenue by Countries

• 7.1 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Revenue by Countries (2014-2019)
• 7.2 China Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 7.3 Japan Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 7.4 Korea Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 7.5 India Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)

8 South America Late Stage Chronic Kidney Disease Drugs Revenue by Countries

• 8.1 South America Late Stage Chronic Kidney Disease Drugs Revenue by Countries (2014-2019)
• 8.2 Brazil Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Late Stage Chronic Kidney Disease Drugs by Countries

• 9.1 Middle East and Africa Late Stage Chronic Kidney Disease Drugs Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 9.3 UAE Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Late Stage Chronic Kidney Disease Drugs Revenue and Growth Rate (2014-2019)

10 Global Late Stage Chronic Kidney Disease Drugs Market Segment by Type

• 10.1 Global Late Stage Chronic Kidney Disease Drugs Revenue and Market Share by Type (2014-2019)
• 10.2 Global Late Stage Chronic Kidney Disease Drugs Market Forecast by Type (2019-2024)
• 10.3 Calcimimetics Revenue Growth Rate (2014-2024)
• 10.4 Vitamin D Sterols Revenue Growth Rate (2014-2024)
• 10.5 Potassium Binders Revenue Growth Rate (2014-2024)
• 10.6 Others Revenue Growth Rate (2014-2024)

11 Global Late Stage Chronic Kidney Disease Drugs Market Segment by Application

• 11.1 Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share by Application (2014-2019)
• 11.2 Late Stage Chronic Kidney Disease Drugs Market Forecast by Application (2019-2024)
• 11.3 Hospital Pharmacies Revenue Growth (2014-2019)
• 11.4 Online Pharnacies Revenue Growth (2014-2019)
• 11.5 Retail Pharmacies Revenue Growth (2014-2019)

12 Global Late Stage Chronic Kidney Disease Drugs Market Size Forecast (2019-2024)

• 12.1 Global Late Stage Chronic Kidney Disease Drugs Market Size Forecast (2019-2024)
• 12.2 Global Late Stage Chronic Kidney Disease Drugs Market Forecast by Regions (2019-2024)
• 12.3 North America Late Stage Chronic Kidney Disease Drugs Revenue Market Forecast (2019-2024)
• 12.4 Europe Late Stage Chronic Kidney Disease Drugs Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Revenue Market Forecast (2019-2024)
• 12.6 South America Late Stage Chronic Kidney Disease Drugs Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Late Stage Chronic Kidney Disease Drugs Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology